CompaniesOricula Therapeutics

Oricula Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

105

By Phase

PHASE2: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

2028

2029

Today

Hover over trial bars to see details

Recent Trials

NCT05730283Collaborator

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

PHASE2Recruiting

105 participants

Started: Jun 2, 2025 · Completed: Feb 29, 2028

Funding History (5)

D

Apr 22, 2020

D

Dec 22, 2017

D

May 15, 2017

D

Jan 21, 2015

D

Nov 4, 2013

Oricula Therapeutics | Biotech Hunter | Biotech Hunter